Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ELF3 |
| Upstream (Parents) |
|---|
| (<<) ESR1 → ELF3 |
| (<<) CDX2 → ELF3 |
| (<<) HOXB9 → ELF3 |
| (<<) GRHL2 → ELF3 |
| (<<) CEBPD → ELF3 |
| (<<) SOX9 → ELF3 |
| (<<) NR3C1 → ELF3 |
| (<<) ZFHX4 → ELF3 |
| (<<) HOXB5 → ELF3 |
| Downstream (Children) |
|---|
| ELF3 → WT1 (>>) |
| ELF3 → HMGA2 (>>) |
| ELF3 → EHF (>>) |
| ELF3 → TSHZ2 (>>) |
| ELF3 → MAF (>>) |
| ELF3 → MNX1 (>>) |
| ELF3 → NR4A1 (>>) |
| ELF3 → TFCP2L1 (>>) |
| ELF3 → NR6A1 (>>) |
| ELF3 → PPARG (>>) |
| ELF3 → NFIC (>>) |
| ELF3 → MYOG (>>) |
| ELF3 → CREB3L1 (>>) |
| ELF3 → ONECUT2 (>>) |
| ELF3 → JUN (>>) |
| ELF3 → TCF7 (>>) |
| ELF3 → BCL11B (>>) |
| ELF3 → BHLHE40 (>>) |
| ELF3 → NR2C1 (>>) |
